ANNOUNCEMENT 04 Nov 2013

In April 2013, the government of Brazil initiated a new anti-dumping investigation and a definitive duty was imposed in April 2015. In March 2020, the definitive duty was suspended due to public interest. In April 2020, a sunset review was initiated. In January 2021, the duty was temporarily suspended for a second time.

NUMBER OF INTERVENTIONS

2

  • 2 harmful
  • 0 neutral
  • 0 liberalising

SOURCE



Federal Official Gazette of Brazil, Issue No. 214, 04.11.2013, Minist?rio do Desenvolvimento, Ind?stria e Com?rcio Exterior, Secretaria de Com?rcio Exterior, Circular No. 64 (01.11.2013), from p. 99:
http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina=99&data=04/11/2013
http://www.desenvolvimento.gov.br/arquivos/dwnl_1383586613.pdf
Federal Official Gazette of Brazil, Issue No. 212, 03.11.2014, Minist?rio do Desenvolvimento, Ind?stria e Com?rcio Exterior, Secretaria de Com?rcio Exterior, Circular No. 67 (31.10.2014), p. 79:
http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina=79&data=03/11/2014
http://www.mdic.gov.br/arquivos/dwnl_1415031452.pdf
Federal Official Gazette of Brazil, Issue No. 81, 30.04.2015, Conselho de Governo, C?mara de Com?rcio Exterior, Resolu??o No. 26 (29.04.2015), from p. 12:
http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina=12&data=30/04/2015
http://www.camex.gov.br/legislacao/interna/id/1377


WTO, Committee on Anti-Dumping Practices - Semi-annual report under article 16.4 of the Agreement - 1 January - 30 June 2020 - Brazil, Document No. G/ADP/N/342/BRA, issued on 18 August 2020: https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S009-DP.aspx?language=E&CatalogueIdList=267518,267326,265808,262902,258515,258265,252341,251193,251161,247976&CurrentCatalogueIdIndex=2&FullTextHash=&HasEnglishRecord=True&HasFrenchRecord=True&HasSpanishRecord=True
Brazilian Foreign Trade Council (Camex), Resolution No. 23 of 25 March 2020, Published in the Official Gazette on 27 March 2020: http://www.camex.gov.br/resolucoes-camex-e-outros-normativos/58-resolucoes-da-camex/2676-resolucao-n-23-de-25-de-marco-de-2020
Ministry of Economy, Circular No. 30 of 29 April 2020, published in the Official Gazette on 30 April 2020: http://www.in.gov.br/en/web/dou/-/circular-n-30-de-29-de-abril-de-2020-254678644
Ministry of Economy, GECEX Resolution 147 of 15 January 2021, issued on the Federal Official Gazette on 16 January 2021: https://www.in.gov.br/web/dou/-/resolucao-gecex-n-147-de-15-de-janeiro-de-2021-299284329

Inception date: 30 Apr 2015 | Removal date: 31 Mar 2020

Anti-dumping

On November 1, 2013, the Secretary for Foreign Trade of the Brazilian Ministry of Development, Industry and Foreign Trade decided to initiate an anti-dumping investigation on imports of plastic blood collection tubes from China, Germany, the United Kingdom and the United States of America (Circular No. 64, 01.11.2013).
The products subject to investigation are classified under the following HS codes: 3822.0090, 3926.9040 and 9018.3999.
The complaint was lodged on April 30, 2013 by Greiner Bio-One Brasil Produtos Médicos Hospitalares Ltda. The investigation started on the day of the publication of the circular in the Federal Official Gazette of Brazil, i.e. on November 4, 2013.
 
On October 31, 2014, the Secretary for Foreign Trade of the Brazilian Ministry of Development, Industry and Foreign Trade decided to extend for up to six months, from November 4, 2014, the investigation period to determine the existence of dumping in exports of plastic blood collection tubes from China, Germany, the United Kingdom and the United States of America (Circular No. 67, 31.10.2014). Circular SECEX No. 67 was published in the Federal Official Gazette of Brazil on November 3, 2014.
 
On April 29th, 2015, the Brazilian authorities decided to impose a definitive anti-dumping duty on imports of plastic blood collection tubes from China, Germany, the United Kingdom and the United States of America (Resolução No. 26, 29.04.2015).
The rate of the duty imposed on imports originating in Germany is 93.3%, at the exception of the company Sarstedt AG & Co. whose exports are subject to a duty of 11.1%. The rate of the duty imposed on imports originating in China is 638.1%, at the exception of the companies Guangzhou Improve Medical Instruments Co. Ltd. (49.5%), Weihai Hongyu Medical Devices Co. Ltd. (97.8%) and Zhejiang Gongdong Medical Plastic Factory (80.7%). The rate of the duty imposed on imports originating in the United States of America is 86.5%, at the exception of the company Becton Dickinson and Company whose exports are subject to a duty of 45.3%. The rate of the duty imposed on imports originating in the United Kingdom is 492.8%, at the exception of the company Becton Dickinson and Company whose exports are subject to a duty of 71.5%.
This definitive anti-dumping duty entered into force on the day of the publication of the resolution in the Federal Official Gazette of Brazil, i.e. on April 30th, 2015, and is applicable for a period of five years.

On 31 March 2020, the Brazilian authorities suspended the definitive duty due to reasons of public interest following the COVID-19 pandemic. 

On 30 April 2020, the Brazilian authorities initiated a sunset review and extended the definitive duty following the temporary suspension period, see related intervention. 

AFFECTED SECTORS

 

AFFECTED PRODUCTS

 
Inception date: 01 Oct 2020 | Removal date: 16 Jan 2020

Anti-dumping

On 30 April 2020, the Brazilian authorities initiated a sunset review of the definitive antidumping duty imposed on imports of plastic blood collection tubes from China, Germany, the United Kingdom and the United States of America. This follows the application lodged on 16 December 2019 by Greiner Bio-One Brasil Produtos Médicos Hospitalares Ltda. The duty will remain in force for the duration of the review.

On 1 October 2020, the temporary suspension on imports of the subject good from China ended and the definitive duty was reinstated. The extended rate of the duty imposed on imports originating in Germany is 93.3%, with the exception of the company Sarstedt AG & Co. whose exports are subject to a duty of 11.1%. The extended rate of the duty imposed on imports originating in China is 638.1%, with the exception of the companies Guangzhou Improve Medical Instruments Co. Ltd. (49.5%), Weihai Hongyu Medical Devices Co. Ltd. (97.8%) and Zhejiang Gongdong Medical Plastic Factory (80.7%). The extended rate of the duty imposed on imports originating in the United States of America is 86.5%, with the exception of the company Becton Dickinson and Company whose exports are subject to a duty of 45.3%. The extended rate of the duty imposed on imports originating in the United Kingdom is 492.8%, with the exception of the company Becton Dickinson and Company whose exports are subject to a duty of 71.5%. The suspension was introduced on 27 March 2020 following the COVID-19 pandemic, see related intervention.

On 15 January 2021, the Brazilian authorities issued Resolution GECEX No. 147 temporarily suspending the definitive duty imposed on imports of plastic blood collection tubes from China, Germany, the United Kingdom and the United States of America due to the COVID-19. The suspension enters into force on 16 Janaury 2021 and is in force until 30 June 2021. The sunset review is still in progress.